Investor Relations

Investor Relations

Stock Information View Detailed Stock Information

NASDAQ: CERC Cerecor, Inc.
Price
Change
Volume
Day Range
52 Week Range

Company Overview

Cerecor is a clinical-stage biopharmaceutical company developing innovative drug candidates to make a difference in the lives of patients with neurological and psychiatric disorders. Cerecor's lead drug candidate is CERC-301, which Cerecor currently intends to explore as a novel treatment for orphan neurological indications.